Work

Targeting CDK2 to circumvent treatment resistance in HR+ breast cancer

Year: 2024

Type: article

Source: Trends in Molecular Medicine

DOI: 10.1016/j.molmed.2024.12.009

Authors: Leire Arrizabalaga, Esmeralda García-Torralba, Lorenzo Galluzzi, Aitziber Buqué

Institutions: Fox Chase Cancer Center, Navarre Institute of Health Research, Centro de Investigación Médica Aplicada, Hospital General Universitario Morales Meseguer, Instituto Murciano de Investigación Biosanitaria, Universidad de Murcia

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: U.S. Department of Defense, Leukemia and Lymphoma Society, National Institutes of Health, Fox Chase Cancer Center, Stand Up To Cancer, National Cancer Institute, Medisch Centrum Leeuwarden

Award: Targeting the BCL2 immune checkpoint to enhance the immunostimulatory effects of radiation in breast cancer

OpenAlex ID: W4405839648

FWCI: 0.577

Cites: 10

Cited by: 2

Related to: 10